Black Diamond Therapeutics Inc (NASDAQ:BDTX) does about 650.14K shares in volume on a normal day but saw 3049550 shares change hands in Monday trading. The company now has a market cap of 308.09M USD. Its current market price is $5.86, marking a decrease of -0.42% compared to the previous close of $5.89. The 52 week high reached by this stock is $6.85 whilst the lowest price level in 52 weeks is $1.43.
Black Diamond Therapeutics Inc (BDTX) has a 20-day trading average at $5.26 and the current price is -14.38% off the 52-week high compared with 310.14% distance from its 52-week low. The 50-day simple moving average of the closing price is $4.94 and its 200-day simple moving average is $3.49. If we look at the stock’s price movements over the week, volatility stands at 8.86%, which decreases to 8.52% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 62.08 to suggest the stock is neutral.
The consensus objective for the share price is $12.80, suggesting that the stock has a potential upside of 54.22% over the period.
Stifel upgraded the stock to “Buy” from Hold on June 30, 2023 at a price target of $2-$10. H.C. Wainwright upgraded its price target at $11.
Black Diamond Therapeutics Inc (BDTX) stock is up 16.83% over the week and 15.68% over the past month. Its price is 108.72% year-to-date and 304.48% over the past year.
The stock last released its quarterly earnings report for quarter ended 12/31/2023, with the company’s earnings per share (EPS) of -0.57 above consensus estimates by 0.04. The company’s next earnings report forecasts estimating quarterly EPS at -0.43 and -1.71 for whole year.
To reach the target analysts have set, the stock logically needs to grow 54.22 percent from here.
The company has a return on investment of -59.34% and return on equity of -70.94%. The beta has a value of 2.58. Price to book ratio is 2.59.
